Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ resapp health limited

ResAppDX needs to do around 400,000 use at $5, each quarter to...

First 36 Last

Share
Profile

Follow
RudeeOne

329 Posts.

139

30/04/20

10:56

Post #: 44346446
Share
Originally posted by eason2946: ↑

Hi all,

Great to see a positive quarterly for RAP as there are no surprises. As mentioned many times before, the next couple months will be the most exciting time for RAP after years of bumpy journey.

My thoughts of this quarterly:

Both Phenix and Coviu will go live before 30th June 2020, $5-$10 per test;
SleepCheck will be available in UK and Australia before 30th June 2020;
Targeting CE mark approval for handheld and wearable prototype devices before 30th June 2020;
Cash balance of $6.9m; cash burn is similar to the previous quarterly (excluding R&D tax incentive)

Market probably won't react too much to this quarterly, but it's good to see everything is well on track and wait for a series of announcements in the next two months

DYOR and GLTAH

Expand

ResAppDX needs to do around 400,000 use at $5, each quarter to be cash flow positive.

I think it's possible.

I'm looking forwards to see the September 2020 Quarterly Report and Appendix 4C.

In between, very possibly more announcements of contracts in Australia and UK.
RAP Price at posting: 18.0¢ Sentiment: Buy Disclosure: Held
13 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 22 more messages in this thread...

First 36 Last

Add RAP (ASX) to my watchlist